176 related articles for article (PubMed ID: 26155936)
1. Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.
Yamada T; Ishiguro N; Oku K; Higuchi I; Nakagawa I; Noguchi A; Yasuda S; Fukumoto T; Iwasaki S; Akizawa K; Furugen A; Yamaguchi H; Iseki K
Biol Pharm Bull; 2015; 38(9):1430-3. PubMed ID: 26155936
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
4. Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.
Heil EL; Lowery AV; Thom KA; Nicolau DP
Pharmacotherapy; 2015 Jan; 35(1):54-8. PubMed ID: 25556715
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.
Krajewski J; Bode-Böger SM; Tröger U; Martens-Lobenhoffer J; Mulrooney T; Mittelstädt H; Russlies M; Kirchner R; Knobloch JK
Int J Antimicrob Agents; 2014 Oct; 44(4):363-6. PubMed ID: 25182711
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa after allogeneic hematopoietic stem cell transplantation with colistin and amikacin inhalation therapy.
Sato M; Honda A; Maki H; Toyama K; Yamaguchi R; Ikeda M; Moriya K; Kurokawa M
J Infect Chemother; 2022 Jan; 28(1):91-94. PubMed ID: 34518095
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
Quinn AL; Parada JP; Belmares J; O'Keefe JP
Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
[TBL] [Abstract][Full Text] [Related]
8. Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa.
Luque S; Sorli L; Li J; Collado S; Barbosa F; Berenguer N; Horcajada JP; Grau S
J Chemother; 2014 Apr; 26(2):122-4. PubMed ID: 24090909
[TBL] [Abstract][Full Text] [Related]
9. [Case of sepsis caused by multidrug-resistant neutropenic-phase Pseudomonas aeruginosa treated successfully with antibiotic combination therapy].
Araoka H; Baba M; Tatsushima K; Takagi S; Matsuno N; Wake A; Taniguchi S; Yoneyama A
Kansenshogaku Zasshi; 2008 Sep; 82(5):466-70. PubMed ID: 18975592
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.
Montero M; Horcajada JP; Sorlí L; Alvarez-Lerma F; Grau S; Riu M; Sala M; Knobel H
Infection; 2009 Oct; 37(5):461-5. PubMed ID: 19499183
[TBL] [Abstract][Full Text] [Related]
11. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
[No Abstract] [Full Text] [Related]
12. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
[TBL] [Abstract][Full Text] [Related]
13. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
14. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa.
Linden PK; Kusne S; Coley K; Fontes P; Kramer DJ; Paterson D
Clin Infect Dis; 2003 Dec; 37(11):e154-60. PubMed ID: 14614688
[TBL] [Abstract][Full Text] [Related]
15. Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP).
Marumo K; Komukai D; Hirose M; Nakamura H; Tanaka H; Ugajin K; Nagashima G; Yoshimura A
J Infect Chemother; 2013 Apr; 19(2):348-51. PubMed ID: 22872187
[TBL] [Abstract][Full Text] [Related]
16. Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
Sorlí L; Luque S; Segura C; Campillo N; Montero M; Esteve E; Herrera S; Benito N; Alvarez-Lerma F; Grau S; Horcajada JP
BMC Infect Dis; 2017 Jan; 17(1):11. PubMed ID: 28056821
[TBL] [Abstract][Full Text] [Related]
17. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician.
Martis N; Leroy S; Blanc V
J Infect; 2014 Jul; 69(1):1-12. PubMed ID: 24631777
[TBL] [Abstract][Full Text] [Related]
18. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections.
Kim EJ; Oh J; Lee K; Yu KS; Chung JY; Hwang JH; Nam EY; Kim HS; Kim M; Park JS; Song KH; Kim ES; Song J; Kim HB
Ther Drug Monit; 2019 Feb; 41(1):102-106. PubMed ID: 30299430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
